(Q35087282)

6 August 2017

title

Early treatment with alglucosidase alpha prolongs long-term survival of infants with Pompe disease (English)

1 reference

6 August 2017

1

Priya S Kishnani

1 reference

6 August 2017

5

Ans Van der Ploeg

1 reference

6 August 2017

Deya Corzo

2

1 reference

6 August 2017

Nancy D Leslie

3

1 reference

6 August 2017

Daniel Gruskin

4

1 reference

6 August 2017

John P Clancy

6

1 reference

6 August 2017

Rosella Parini

7

1 reference

6 August 2017

Gilles Morin

8

1 reference

6 August 2017

Michael Beck

9

1 reference

6 August 2017

Mislen S Bauer

10

1 reference

6 August 2017

Mikael Jokic

11

1 reference

6 August 2017

Chen-En Tsai

12

1 reference

6 August 2017

Brian W H Tsai

13

1 reference

6 August 2017

Claire Morgan

14

1 reference

6 August 2017

Tara O'Meara

15

1 reference

6 August 2017

Susan Richards

16

1 reference

6 August 2017

Elisa C Tsao

17

1 reference

6 August 2017

Hanna Mandel

18

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 September 2009

1 reference

6 August 2017

1 reference

6 August 2017

volume

66

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

329-335

1 reference

Enhanced response to enzyme replacement therapy in Pompe disease after the induction of immune tolerance

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129995

Glycogen storage disease types I and II: treatment updates

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129995

Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129995

Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129995

Pompe disease in infants and children

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129995

Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129995

The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129995

Enzyme therapy for pompe disease with recombinant human alpha-glucosidase from rabbit milk

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129995

Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129995

Towards a molecular therapy for glycogen storage disease type II (Pompe disease).

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129995

Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129995

Elimination of antibodies to recombinant enzyme in Pompe's disease.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129995

A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129995

Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129995

Nonparametric Estimation from Incomplete Observations

27 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B24E94

10.1203/PDR.0B013E3181B24E94

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

6 August 2017

0 references

1 reference

6 August 2017

1 reference